IL4 and rheumatoid arthritis: IL‐4 has also shown disease‐modifying effects in the RA animal models.[83] In the CIA mice, combined treatment with MSCs and IL‐4 reduced pro‐inflammatory cytokines in the joints and reduced joint inflammation.